Mainstay Medical

Mainstay Medical is a global medical device company focused on developing and commercializing innovative therapeutic solutions for adults with mechanical chronic low back pain (CLBP). Founded in 2008 in Minneapolis, Minnesota, the company is now headquartered in Dublin, Ireland, and has expanded its operations internationally, including subsidiaries in the United States, Australia, Germany, and the Netherlands. The company's core product, ReActiv8, is an implantable Restorative Neurostimulation™ system designed to treat disabling mechanical CLBP by restoring function to the lumbar multifidus muscle, essential for spinal stability. ReActiv8 is the first FDA-approved restorative treatment for this condition, aiming to alleviate pain and improve patient function. Mainstay Medical supports its therapy with extensive clinical evidence from trials and has achieved regulatory milestones, including CE marking in Europe and FDA approval in the United States. The company collaborates with healthcare providers and payers to enhance access to ReActiv8 therapy, ultimately striving to improve patient outcomes in chronic pain management.

• Employees 180
• Founded 2008
• Annual Revenue $1497000
• Total Funding $357500400